FDA has just approved the expansion of Pfizer’s Xalkori treatment to include patients suffering from a rare mutated form of advanced non-small-cell lung cancer
Pfizer Inc. announced Monday that it will be buying Allergan Plc. in an agreement that is worth $160 billion.
